Meta-analysis questions growing insulin use in type 2 diabetes

INSULIN is being prescribed to millions of patients worldwide despite having no long-term benefit in type 2 diabetes, researchers say after conducting a large meta-analysis.

And, they warn, the push for low HBA1c targets is leading to increasing numbers of patients being put on insulin.

Not only is there no evidence for a benefit, insulin is likely to cause hypoglycaemic events or major hypoglycaemia compared with oral medication, the French researchers say.

Their analysis of 20 randomised controlled trials involving more than 18,000 patients

Latest

Trending